| Zaman aralığı | Tahmini Fiyat | Geçmiş | Tarihsel | İç yüzü |
|---|---|---|---|---|
| Yarın | $8.45 ▼ -0.80% | Dün | $8.55 ▲ +0.33% | Tomorrow's Xilio Therapeutics Inc. Common Stock (XLO) setup is anchored to $8.52 and targets $8.45 (-0.80%). The near-term read is downside; watch $8.78 / $8.26 because daily realized volatility is about 4.10%. |
Tomorrow's Xilio Therapeutics Inc. Common Stock (XLO) setup is anchored to $8.52 and targets $8.45 (-0.80%). The near-term read is downside; watch $8.78 / $8.26 because daily realized volatility is about 4.10%. | ||||
| Hafta | $8.31 ▼ -2.48% | Geçen hafta | $8.61 ▲ +1.04% | The 7-day Xilio Therapeutics Inc. Common Stock model moves from $8.61 to $8.31 (-2.48%). It gives downside momentum context for this stock, so breaks around $8.78 / $8.26 matter more than a single tick. |
The 7-day Xilio Therapeutics Inc. Common Stock model moves from $8.61 to $8.31 (-2.48%). It gives downside momentum context for this stock, so breaks around $8.78 / $8.26 matter more than a single tick. | ||||
| Ay | $8.07 ▼ -5.27% | Geçen ay | $8.71 ▲ +2.21% | The 1-month Xilio Therapeutics Inc. Common Stock target is $8.07 (-5.27%), compared with the live reference near $8.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Xilio Therapeutics Inc. Common Stock target is $8.07 (-5.27%), compared with the live reference near $8.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Yıl | $7.71 ▼ -9.46% | Geçen sene | $8.86 ▲ +3.97% | The 1-year Xilio Therapeutics Inc. Common Stock scenario points to $7.71 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Xilio Therapeutics Inc. Common Stock scenario points to $7.71 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Yıl | $6.88 ▼ -19.29% | 5 Yıl Önce | $9.21 ▲ +8.10% | The 5-year Xilio Therapeutics Inc. Common Stock view is $6.88 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Xilio Therapeutics Inc. Common Stock view is $6.88 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Gösterge | Değer | Sinyal |
|---|---|---|
| Price | $8.52 | Mid |
| Daily Change | +0.83% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 59% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $8.52 | Daily Change | +0.83% |
| Market Cap | $49.27M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.